ML15147A222: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
 
(2 intermediate revisions by the same user not shown)
Line 3: Line 3:
| issue date = 05/14/2015
| issue date = 05/14/2015
| title = Shine Medical Technologies V. 0 - Chapter 14 - Technical Specifications
| title = Shine Medical Technologies V. 0 - Chapter 14 - Technical Specifications
| author name = Bynum R V
| author name = Bynum R
| author affiliation = Shine Medical Technologies, Inc
| author affiliation = Shine Medical Technologies, Inc
| addressee name =  
| addressee name =  
Line 16: Line 16:


=Text=
=Text=
{{#Wiki_filter:Chapter 14 - Technical SpecificationsTable of ContentsSHINE Medical Technologies14-iRev. 0 CHAPTER 14TECHNICAL SPECIFICATIONSTable of Contents SectionTitlePage14a1HETEROGENEOUS REACTOR TECHNICAL SPECIFICATIONS.............14a1-114a2IRRADIATION FACILITY TECHNICAL SPECIFICATIONS.........................14a2-114a
{{#Wiki_filter:Chapter 14 - Technical Specifications                                                                Table of Contents CHAPTER 14 TECHNICAL SPECIFICATIONS Table of Contents Section                                        Title                                                              Page 14a1      HETEROGENEOUS REACTOR TECHNICAL SPECIFICATIONS .............14a1-1 14a2      IRRADIATION FACILITY TECHNICAL SPECIFICATIONS.........................14a2-1 14a


==2.1INTRODUCTION==
==2.1    INTRODUCTION==
.........................................................................................14a2-214a2.2SAFETY LIMITS AND LIMITING SAFETY SYSTEM SETTINGS................14a2-314a2.3LIMITING CONDITIONS FOR OPERATION...............................................14a2-414a2.4SURVEILLANCE REQUIREMENTS............................................................14a2-5 14a2.5DESIGN FEATURES...................................................................................14a2-614a2.6ADMINISTRATIVE CONTROLS..................................................................14a2-714a
.........................................................................................14a2-2 14a2.2    SAFETY LIMITS AND LIMITING SAFETY SYSTEM SETTINGS................14a2-3 14a2.3    LIMITING CONDITIONS FOR OPERATION ...............................................14a2-4 14a2.4    SURVEILLANCE REQUIREMENTS............................................................14a2-5 14a2.5    DESIGN FEATURES ...................................................................................14a2-6 14a2.6    ADMINISTRATIVE CONTROLS ..................................................................14a2-7 14a


==2.7REFERENCES==
==2.7    REFERENCES==
............................................................................................14a2-1814bTECHNICAL SPECIFICATIONS OF PROCESSES OUTSIDE THE IRRADIATIONFACILITY.............................................................................14b-114b.1INTRODUCTION.........................................................................................14b-114b.2SAFETY LIMITS AND LIMITING SAFETY SYSTEM SETTINGS................14b-214b.2.1SAFETY LIMITS FOR PROCESSING IRRADIATED SPECIAL NUCLEARMATERIAL OUTSIDE OF THE REACTOR...............................14b-214b.2.2SAFETY LIMITS FOR PROCESSING UNIRRADIATED SPECIAL NUCLEARMATERIAL OUTSIDE OF THE IRRADIATION FACILITY ........14b-214b.2.3SAFETY LIMITS FOR RADIOCHEMICAL PROCESSING..........................14b-214b.2.4SAFETY LIMITS FOR CHEMICAL PROCESSING.....................................14b-2 14b.2.5LIMITING SAFETY SYSTEM SETTINGS....................................................14b-214b.3LIMITING CONDITIONS FOR OPERATION...............................................14b-3 14b.3.1PRIMARY PROCESS COMPONENTS AND SYSTEMS.............................14b-314b.3.2CONTAINMENT AND CONFINEMENT.......................................................14b-3 14b.3.3VENTILATION SYSTEMS...........................................................................14b-314b.3.4EMERGENCY ELECTRICAL POWER........................................................14b-314b.3.5RADIATION MONITORING SYSTEMS AND EFFLUENTS........................14b-314b.4SURVEILLANCE REQUIREMENTS............................................................14b-414b.5DESIGN FEATURES...................................................................................14b-5 14b.6ADMINISTRATIVE CONTROLS..................................................................14b-614b.7REFERENCES............................................................................................14b-7 Chapter 14 - Technical SpecificationsList of TablesSHINE Medical Technologies14-iiRev. 0List of Tables NumberTitle14a2-1SHINE Facility Proposed Parame ters for Technical Specifications Chapter 14 - Technical SpecificationsList of FiguresSHINE Medical Technologies14-iiiRev. 0List of Figures NumberTitleNone Acronyms and Abbreviations Acronym/AbbreviationDefinition10 CFRTitle 10 of the Code of Federal Regulations ANSAmerican Nuclear Society ANSIAmerican National Standards Institute IFirradiation facility ISAIntegrated Safety Analysis IUirradiation unit LCOlimiting condition of operation LSSSlimiting safety system settingLWPSlight water pool systemNGRSnoble gas removal system PCLSprimary closed loop cooling system PSBprimary system boundary PVVSprocess vessel vent system RCAradiologically controlled area RPFradioisotope production facility RVZ1RCA ventilation system Zone 1 RVZ2RCA ventilation system Zone 2 SHINESHINE Medical Technologies, Inc.
............................................................................................14a2-18 14b        TECHNICAL SPECIFICATIONS OF PROCESSES OUTSIDE THE IRRADIATION FACILITY .............................................................................14b-1 14b.1      INTRODUCTION .........................................................................................14b-1 14b.2      SAFETY LIMITS AND LIMITING SAFETY SYSTEM SETTINGS................14b-2 14b.2.1    SAFETY LIMITS FOR PROCESSING IRRADIATED SPECIAL NUCLEAR MATERIAL OUTSIDE OF THE REACTOR ...............................14b-2 14b.2.2    SAFETY LIMITS FOR PROCESSING UNIRRADIATED SPECIAL NUCLEAR MATERIAL OUTSIDE OF THE IRRADIATION FACILITY ........14b-2 14b.2.3    SAFETY LIMITS FOR RADIOCHEMICAL PROCESSING ..........................14b-2 14b.2.4    SAFETY LIMITS FOR CHEMICAL PROCESSING .....................................14b-2 14b.2.5    LIMITING SAFETY SYSTEM SETTINGS....................................................14b-2 14b.3      LIMITING CONDITIONS FOR OPERATION ...............................................14b-3 14b.3.1    PRIMARY PROCESS COMPONENTS AND SYSTEMS.............................14b-3 14b.3.2    CONTAINMENT AND CONFINEMENT.......................................................14b-3 14b.3.3    VENTILATION SYSTEMS ...........................................................................14b-3 14b.3.4    EMERGENCY ELECTRICAL POWER ........................................................14b-3 14b.3.5    RADIATION MONITORING SYSTEMS AND EFFLUENTS ........................14b-3 14b.4      SURVEILLANCE REQUIREMENTS............................................................14b-4 14b.5      DESIGN FEATURES ...................................................................................14b-5 14b.6      ADMINISTRATIVE CONTROLS ..................................................................14b-6 14b.7      REFERENCES ............................................................................................14b-7 SHINE Medical Technologies                         14-i                                                              Rev. 0
SLsafety limit SNMspecial nuclear material TOGSTSV off-gas system TSVtarget solution vesselChapter 14 - Technical SpecificationsAcronyms and AbbreviationsSHINE Medical Technologies14-ivRev. 1 Chapter 14 - Technical SpecificationsHeter ogeneous Reactor Technical SpecificationsSHINE Medical Technologies14a1-1Rev. 0CHAPTER 14 TECHNICAL SPECIFICATION14a1HETEROGENEOUS REACTOR TECHNICAL SPECIFICATIONS The SHINE Medical Technologies, Inc. (SHINE) facility is not a heterogeneous reactor facility; therefore, this section does not apply.
Chapter 14 - Technical SpecificationsIrradiation Facility Technical SpecificationsSHINE Medical Technologies14a2-1Rev. 014a2IRRADIATION FACILITY TECHNICAL SPECIFICATIONS This section encompasses the technical spec ifications for the processes involving special nuclear material (SNM), radioisotopes, and chemicals inside the irradiation facility (IF).In accordance with the requirements of Title 10 of the Code of Federal Regulations (10 CFR) 50.34 (a)(5), this section identifies the variables and conditions that will likely be the subjects of technical specifications for the SHINE facility. These may change with the operating license


application. These variables and conditions are based on the preliminary design of the SHINE facility. The technical specifications will be submitted with the operating license application.These proposed variables have been identified on the premise that this material presents a sound framework upon which a final, complete set of technical specifications can be provided with the operating license application.
Chapter 14 - Technical Specifications                                        List of Tables List of Tables Number                                      Title 14a2-1      SHINE Facility Proposed Parameters for Technical Specifications SHINE Medical Technologies                  14-ii                                    Rev. 0
Chapter 14 - Technical SpecificationsIntroductionSHINE Medical Technologies14a2-2Rev. 014a


==2.1INTRODUCTION==
Chapter 14 - Technical Specifications                List of Figures List of Figures Number                                    Title None SHINE Medical Technologies                  14-iii            Rev. 0
The format and content of the technical specifications will be written with the guidance provided in American National Standards Institute (ANSI)/American Nuclear Society (ANS) 15.1, "The Development of Technical Specifications for Research Reactors" (ANSI/ANS, 2007). The technical specifications for non-power reactors include the categories in 10 CFR 50.36 for production and utilization facilities.Normal operation of the SHINE facility within the limits of technical specifications will not result in off-site radiation exposure in excess of 10 CFR 20 guidelines.
 
Chapter 14 - Technical SpecificationsSafety Limits and Limiting Safety System SettingsSHINE Medical Technologies14a2-3Rev. 014a2.2SAFETY LIMITS AND LIMITING SAFETY SYSTEM SETTINGSSafety limits (SLs) will be placed on important process variables as necessary to reasonably preserve the integrity of the primary system boundary (PSB) and prevent the uncontrolled release of radioactivity. For the SHINE IF, the PSB is the target solution vessel (TSV), TSV dump tank, TSV off-gas system (TOGS), and associated piping and components. SLs may also be established for the character and quality of the target solution.Limiting safety system settings (LSSSs) are settings for automatic protective devices related to those variables having significant safety functi ons. These settings ensure that automatic protective action will correct the abnormal situation before an SL is exceeded.Refer to Table 14a2-1 for the SLs and LSSSs associated with the PSB. The justifications for the variables chosen are given in the section/subsection listed in the Table 14a2-1.
Chapter 14 - Technical Specifications                              Acronyms and Abbreviations Acronyms and Abbreviations Acronym/Abbreviation                      Definition 10 CFR                                    Title 10 of the Code of Federal Regulations ANS                                      American Nuclear Society ANSI                                      American National Standards Institute IF                                        irradiation facility ISA                                      Integrated Safety Analysis IU                                        irradiation unit LCO                                      limiting condition of operation LSSS                                      limiting safety system setting LWPS                                      light water pool system NGRS                                      noble gas removal system PCLS                                      primary closed loop cooling system PSB                                      primary system boundary PVVS                                      process vessel vent system RCA                                      radiologically controlled area RPF                                      radioisotope production facility RVZ1                                      RCA ventilation system Zone 1 RVZ2                                      RCA ventilation system Zone 2 SHINE                                    SHINE Medical Technologies, Inc.
Chapter 14 - Technical SpecificationsLimiting Conditions for OperationSHINE Medical Technologies14a2-4Rev. 014a2.3LIMITING CONDITIONS FOR OPERATIONLimiting conditions of operations (LCOs) are derived from the safety analyses and are implemented administratively or by control an d monitoring circuitry to ensure safe operation of the irradiation facility. The LCOs are the lowest functional capability or performance level required for safe operation of the irradiation facility.Table 14a2-1 shows LCOs associated with the irradiation facility. The justifications for the variables chosen are given in the sections listed in the table.
SL                                        safety limit SNM                                      special nuclear material TOGS                                      TSV off-gas system TSV                                      target solution vessel SHINE Medical Technologies                14-iv                                      Rev. 1
Chapter 14 - Technical SpecificationsSurveillance RequirementsSHINE Medical Technologies14a2-5Rev. 014a2.4SURVEILLANCE REQUIREMENTSSurveillance requirements will be provided in the technical specifications.
 
Chapter 14 - Technical SpecificationsDesign FeaturesSHINE Medical Technologies14a2-6Rev. 014a2.5DESIGN FEATURESDesign features that will be provided in the technical specifications are the features of the SHINE facility, such as materials of construction and geometric arrangements that would have a significant effect on safety if these features were altered or modified. The requirements of 10CFR 50.36(c)(4) are specified here as they pertain to the above referenced processes (see Table 14a2-1)
Chapter 14 - Technical Specifications      Heterogeneous Reactor Technical Specifications CHAPTER 14 TECHNICAL SPECIFICATION 14a1  HETEROGENEOUS REACTOR TECHNICAL SPECIFICATIONS The SHINE Medical Technologies, Inc. (SHINE) facility is not a heterogeneous reactor facility; therefore, this section does not apply.
.
SHINE Medical Technologies              14a1-1                                        Rev. 0
Chapter 14 - Technical SpecificationsAdministrative ControlsSHINE Medical Technologies14a2-7Rev. 114a2.6ADMINISTRATIVE CONTROLSAdministrative controls will be provided in the technical specifications.Examples of the proposed subjects of administrative controls are provided below:
 
Chapter 14 - Technical Specifications                    Irradiation Facility Technical Specifications 14a2        IRRADIATION FACILITY TECHNICAL SPECIFICATIONS This section encompasses the technical specifications for the processes involving special nuclear material (SNM), radioisotopes, and chemicals inside the irradiation facility (IF).
In accordance with the requirements of Title 10 of the Code of Federal Regulations (10 CFR) 50.34 (a)(5), this section identifies the variables and conditions that will likely be the subjects of technical specifications for the SHINE facility. These may change with the operating license application. These variables and conditions are based on the preliminary design of the SHINE facility. The technical specifications will be submitted with the operating license application.
These proposed variables have been identified on the premise that this material presents a sound framework upon which a final, complete set of technical specifications can be provided with the operating license application.
SHINE Medical Technologies                      14a2-1                                          Rev. 0
 
Chapter 14 - Technical Specifications                                                    Introduction 14a
 
==2.1 INTRODUCTION==
 
The format and content of the technical specifications will be written with the guidance provided in American National Standards Institute (ANSI)/American Nuclear Society (ANS) 15.1, The Development of Technical Specifications for Research Reactors (ANSI/ANS, 2007). The technical specifications for non-power reactors include the categories in 10 CFR 50.36 for production and utilization facilities.
Normal operation of the SHINE facility within the limits of technical specifications will not result in off-site radiation exposure in excess of 10 CFR 20 guidelines.
SHINE Medical Technologies                    14a2-2                                            Rev. 0
 
Chapter 14 - Technical Specifications            Safety Limits and Limiting Safety System Settings 14a2.2      SAFETY LIMITS AND LIMITING SAFETY SYSTEM SETTINGS Safety limits (SLs) will be placed on important process variables as necessary to reasonably preserve the integrity of the primary system boundary (PSB) and prevent the uncontrolled release of radioactivity. For the SHINE IF, the PSB is the target solution vessel (TSV), TSV dump tank, TSV off-gas system (TOGS), and associated piping and components. SLs may also be established for the character and quality of the target solution.
Limiting safety system settings (LSSSs) are settings for automatic protective devices related to those variables having significant safety functions. These settings ensure that automatic protective action will correct the abnormal situation before an SL is exceeded.
Refer to Table 14a2-1 for the SLs and LSSSs associated with the PSB. The justifications for the variables chosen are given in the section/subsection listed in the Table 14a2-1.
SHINE Medical Technologies                    14a2-3                                      Rev. 0
 
Chapter 14 - Technical Specifications                            Limiting Conditions for Operation 14a2.3        LIMITING CONDITIONS FOR OPERATION Limiting conditions of operations (LCOs) are derived from the safety analyses and are implemented administratively or by control and monitoring circuitry to ensure safe operation of the irradiation facility. The LCOs are the lowest functional capability or performance level required for safe operation of the irradiation facility.
Table 14a2-1 shows LCOs associated with the irradiation facility. The justifications for the variables chosen are given in the sections listed in the table.
SHINE Medical Technologies                      14a2-4                                      Rev. 0
 
Chapter 14 - Technical Specifications                                  Surveillance Requirements 14a2.4    SURVEILLANCE REQUIREMENTS Surveillance requirements will be provided in the technical specifications.
SHINE Medical Technologies                  14a2-5                                        Rev. 0
 
Chapter 14 - Technical Specifications                                              Design Features 14a2.5      DESIGN FEATURES Design features that will be provided in the technical specifications are the features of the SHINE facility, such as materials of construction and geometric arrangements that would have a significant effect on safety if these features were altered or modified. The requirements of 10 CFR 50.36(c)(4) are specified here as they pertain to the above referenced processes (see Table 14a2-1).
SHINE Medical Technologies                      14a2-6                                        Rev. 0
 
Chapter 14 - Technical Specifications                                      Administrative Controls 14a2.6      ADMINISTRATIVE CONTROLS Administrative controls will be provided in the technical specifications.
Examples of the proposed subjects of administrative controls are provided below:
Procedures Written procedures shall be established, implemented, and maintained covering activities described in the following Programs.
Procedures Written procedures shall be established, implemented, and maintained covering activities described in the following Programs.
Programs*Criticality-safety*ALARA (includes use of accelerator and hot cell audible and visual warnings)
Programs
*Procurement and use of transport and waste containers*Fire protection (includes installed and transient combustible loading, performance of hot work, deuterium source vessel integrity, fire watch requirements, use and storage of flammable and combustible liquids and gasses)*Solvent control (includes control of process residence times, solvent quality control, and solvent solution sampling and analysis)*Tritium control (includes inventory control and sampling)*Light water coolant activity monitoring
* Criticality-safety
*Chemical control Chapter 14 - Technical Specifications IntroductionSHINE Medical Technologies14a2-8Rev. 1Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications(Sheet 1 of 10)
* ALARA (includes use of accelerator and hot cell audible and visual warnings)
Chapter/Section/ Subsection Reference per ANSI/ANS-15.1-2007Section NameSLs and LSSSBasis2  SLs and LSSS2.1SLs*TSV power *Uranium concentration*Uranium enrichment
* Procurement and use of transport and waste containers
*Quantities of radioactive materials 13a2.1.8/13a2.2.8 Large undamped power oscillations 13a2.1.2/13a2.2.2 Insertion of excess reactivity 13a2.1.11/13a2.2.11 PSB System interaction events13b.2.4 Critical equipment malfunction13b.2.5 Inadvertent nuclear criticality in the radioisotope production facility13b.2.6 Radioisotope production facility fire2.2Limiting Safety System Settings*TSV LSSS a. TSV cover gas hydrogen concentration highb. TSV neutron fl ux high, source rangec. TSV neutron flux high, high range 13a2.1.2/13a2.2.2 Excess reactivity13a2.1.8/13a2.2.8 Large undamped power oscillations
* Fire protection (includes installed and transient combustible loading, performance of hot work, deuterium source vessel integrity, fire watch requirements, use and storage of flammable and combustible liquids and gasses)
* Solvent control (includes control of process residence times, solvent quality control, and solvent solution sampling and analysis)
* Tritium control (includes inventory control and sampling)
* Light water coolant activity monitoring
* Chemical control SHINE Medical Technologies                    14a2-7                                      Rev. 1
 
Chapter 14 - Technical Specifications                                                                                                 Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 1 of 10)
Chapter/
Section/
Subsection Reference per ANSI/ANS-1 5.1-2007    Section Name              SLs and LSSS                                              Basis 2              SLs and LSSS 2.1            SLs
* TSV power                           13a2.1.8/13a2.2.8 Large undamped power oscillations
* Uranium concentration              13a2.1.2/13a2.2.2 Insertion of excess reactivity
* Uranium enrichment                  13a2.1.11/13a2.2.11 PSB System interaction events
* Quantities of radioactive materials 13b.2.4 Critical equipment malfunction 13b.2.5 Inadvertent nuclear criticality in the radioisotope production facility 13b.2.6 Radioisotope production facility fire 2.2            Limiting Safety
* TSV LSSS                             13a2.1.2/13a2.2.2 Excess reactivity System          a. TSV cover gas hydrogen             13a2.1.8/13a2.2.8 Large undamped power oscillations Settings          concentration high                  13a2.1.9/13a2.2.9 Detonation and deflagration in primary system boundary
: b. TSV neutron flux high, source range
: c. TSV neutron flux high, high range SHINE Medical Technologies                                      14a2-8                                                                    Rev. 1
 
Chapter 14 - Technical Specifications                                                                                          Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 2 of 10)
Chapter/
Section/
Subsection Reference per ANSI/ANS-1 5.1-2007    Section Name              LCO or Condition                                        Basis 3              LCOs 3.1            TSV and
* Target solution parameters:        13a2.1.2/13a2.2.2 Excess reactivity Target          a. Precipitation catalyst              13a2.1.8/13a2.2.8 Large undamped power oscillations Solution          concentration                      13a2.1.11/13a2.2.11 Primary system boundary interaction Parameters                                            events
: b. Uranium concentration
: c. Uranium enrichment
: d. Fission product activity based on the maximum number of cycles prior to target solution cleanup
* TSV parameters and                  13a2.1.2/13a2.2.2 Excess reactivity operational constraints:            13a2.1.3/13a2.2.3 Reduction of cooling
: a. High fill flow rate                13a2.1.8/13a2.2.8 Large undamped power oscillations
: b. Maximum bulk temperature
: c. Minimum bulk temperature
: d. Void coefficient design value
: e. Temperature coefficient design value SHINE Medical Technologies                                        14a2-9                                                            Rev. 0


13a2.1.9/13a2.2.9 Detonation and deflagration in primary system boundary Chapter 14 - Technical Specifications IntroductionSHINE Medical Technologies14a2-9Rev. 0Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications(Sheet 2 of 10)Chapter/Section/ Subsection Reference perANSI/ANS-15.1-2007Section NameLCO or ConditionBasis3LCOs3.1TSV and Target SolutionParameters*Target solution parameters:a.Precipitation catalyst concentrationb.Uranium concentrationc.Uranium enrichmentd.Fission product activity based on the maximum number of cycles prior to target solution cleanup13a2.1.2/13a2.2.2 Excess reactivity13a2.1.8/13a2.2.8 Large undamped power oscillations 13a2.1.11/13a2
Chapter 14 - Technical Specifications                                                                                           Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 3 of 10)
.2.11 Primary system bo undary interaction events*TSV parameters and operationalconstraints: a.High fill flow rateb.Maximum bulk temperature c.Minimum bulk temperature d.Void coefficient design valuee.Temperature coefficient design value13a2.1.2/13a2.2.2 Excess reactivity 13a2.1.3/13a2.2.3 Reduction of cooling 13a2.1.8/13a2.2.8 Large undamped power oscillations Chapter 14 - Technical Specifications IntroductionSHINE Medical Technologies14a2-10Rev. 0Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 3 of 10)
Chapter/
Chapter/Section/ Subsection Referenceper ANSI/ANS-15.1-2007Section NameLCO or ConditionBasis3.2TSV Control and Safety Systems*TRPS: Required channels operable per Table 3.2.1 Table 3.2.1 (Channel monitored, number of ch annels required, allowable value, nominal setpoint, permissible bypass or other conditions)a.TSV cover gas hydrogen concentration highb. TSV neutron fl ux high, source rangec. TSV neutron flux high, high range
Section/
Subsection Reference per ANSI/ANS-1 5.1-2007    Section Name              LCO or Condition                                        Basis 3.2            TSV Control
* TRPS: Required channels            13a2.1.2/13a2.2.2 Excess reactivity and Safety        operable per Table 3.2.1 13a2.1.3/13a2.2.3 Reduction of cooling Systems            Table 3.2.1 (Channel monitored, 13a2.1.8/13a2.2.8 Large undamped power oscillations number of channels required, allowable value, nominal setpoint, 13a2.1.9/13a2.2.9 Detonation and deflagration in primary permissible bypass or other       system boundary conditions)
: a. TSV cover gas hydrogen concentration high
: b. TSV neutron flux high, source range
: c. TSV neutron flux high, high range
: d. Loss of PCLS flow
: d. Loss of PCLS flow
: e. High PCLS temperaturef. Primary closed loop cooling system (PCLS) low temperatureg.ESFASh.Manual13a2.1.2/13a2.2.
: e. High PCLS temperature
2 Excess reactivity13a2.1.3/13a2.2.3 Reduction of cooling 13a2.1.8/13a2.2.8 Large undamped power oscillations 13a2.1.9/13a2.2.9 Detonation and deflagration in primary system boundary Chapter 14 - Technical Specifications IntroductionSHINE Medical Technologies14a2-11Rev. 0Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications(Sheet 4 of 10)
: f. Primary closed loop cooling system (PCLS) low temperature
Chapter/Section/ Subsection Referenceper ANSI/ANS-15.1-2007Section NameLCO or ConditionBasis 3.2(cont'd)TSV Control and Safety Systems*TOGSa. TOGS operable and in operation (operable incl udes blowers, recombiner beds, and interlock with noble gas removal system [NGRS])b. Hydrogen monitoring indicationc. Hydrogen concentration within limits 13a2.1.5/13a2.2.5 Loss of off-site power 13a2.1.11/13a2.2.11 Primary system boundary interaction events 13b.2.1 Maximum hypothetical ac cident in the radioisotope production facility (RPF)*Safety system equipment
: g. ESFAS
: a. TSV dump valvesb. Neutron driver circuit breakers c. Neutron driver interlock with TSV fill operationd. Dump tank empty during startup and irradiation
: h. Manual SHINE Medical Technologies                                      14a2-10                                                              Rev. 0
: e. Fill valves13a2.1.2/13a2.2.2 Excess reactivity13a2.1.3/13a2.2.3 Reduction of cooling 13a2.1.8/13a2.2.8Large undamped power oscillations13a2.1.9/13a2.2.9 Detonation and deflagration in primary system boundary3.3Coolant Systems*Light water pool system (LWPS)a. Temperature upper limit and temperature lower limitb. Level13a2.1.2/13a2.2.2 Excess reactivity 13a2.1.3/13a2.2.3 Reduction of cooling 13a2.1.11/13a2.2.11 Primary system boundary interaction events Chapter 14 - Technical Specifications IntroductionSHINE Medical Technologies14a2-12Rev. 0Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications(Sheet 5 of 10)
 
Chapter/Section/Subsection Referenceper ANSI/ANS-15.1-2007Section NameLCO or ConditionBasis3.4Containment or Confinement*Tritium purification system (TPS) glove box system or confinement*IU and TOGS shielded cell confinement isolation valves*RPF confinement isolation valves13a2.1.7/13a2.2.7 Mishandling or malfunction of equipment affecting the PSB 13a2.1.12.2/13a2.2.12.2 Irradiation facility fires3.5Ventilation Systems*Ventilation systems (RCA ventilation system Zone 1 [RVZ1]/RCA ventilation system Zone 2 [RVZ2])
Chapter 14 - Technical Specifications                                                                                               Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 4 of 10)
: a. Isolation dampers
Chapter/
: b. Filters13a2.1.4/13a2.2.4 Mishandling or malfunction of target solution13a2.1.7/13a2.2.7 Mishandling or malfunction of equipment affecting the PSB 13a2.1.12.3/13a2.2.12.3 TPS design basis accident13b.2.4 Critical equipment malfunction*Process vessel vent system (PVVS):
Section/
Blowers operable 13a2.1.5/13a2.2.5 Loss of off-site power 13a2.1.11/13a2.2.11 Primary system boundary interaction events3.6Emergency Power*Emergency power system operable13a2.1.5/13a2.2.5 Loss of off-site power 13a2.1.11/13a2.2.11 Primary system boundary interaction events Chapter 14 - Technical Specifications IntroductionSHINE Medical Technologies14a2-13Rev. 1Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications(Sheet 6 of 10)
Subsection Reference per ANSI/ANS-1 5.1-2007  Section Name                LCO or Condition                                          Basis 3.2           TSV Control and
Chapter/Section/Subsection Referenceper ANSI/ANS-15.1-2007Section NameLCO or ConditionBasis3.7Radiation Monitoring Systems and Effluents*Noble gas storage tank activity*Target solution transfer decay time13b.2.4 Critical equipment malfunction*Radiation monitoring systems
* TOGS                                     13a2.1.5/13a2.2.5 Loss of off-site power (contd)      Safety Systems a. TOGS operable and in operation            13a2.1.11/13a2.2.11 Primary system boundary interaction (operable includes blowers,            events recombiner beds, and interlock with 13b.2.1 Maximum hypothetical accident in the radioisotope noble gas removal system [NGRS])
: a. Channels and interlocks with ventilation systems
production facility (RPF)
: b. Monitoring equipment operable13a2.1.4/13a2.2.4 Mishandling or malfunction of target solution13a2.1.7/13a2.2.7 Mishandling or malfunction of equipment affecting the PSB13a2.1.12.3/13a2.2.12.3 TPS design basis accident3.8ExperimentsN/A N/A3.9Facility Specific LCOs*Criticality-safe sumpsa. Sump pump operableb. Sump level detectors operable13b.2.5 Inadvertent nuclear criticality in the radioisotope production facility*Radiological Integrated Control Sys-tem (RICS)13b.2.4 Critical Equipment Malfunction Chapter 14 - Technical Specifications IntroductionSHINE Medical Technologies14a2-14Rev. 0Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications(Sheet 7 of 10)
: b. Hydrogen monitoring indication
Chapter/Section/ Subsection Reference per ANSI/ANS-15.1-2007Section NameDesign FeaturesBasis5Design Features5.1Site and Facility Description*Building design to resist external event such as airplane crash, tornados and  
: c. Hydrogen concentration within limits
* Safety system equipment                13a2.1.2/13a2.2.2 Excess reactivity
: a. TSV dump valves                        13a2.1.3/13a2.2.3 Reduction of cooling
: b. Neutron driver circuit breakers        13a2.1.8/13a2.2.8 Large undamped power oscillations
: c. Neutron driver interlock with TSV fill 13a2.1.9/13a2.2.9 Detonation and deflagration in primary system operation                              boundary
: d. Dump tank empty during startup and irradiation
: e. Fill valves 3.3          Coolant
* Light water pool system (LWPS)         13a2.1.2/13a2.2.2 Excess reactivity Systems          a. Temperature upper limit and            13a2.1.3/13a2.2.3 Reduction of cooling temperature lower limit 13a2.1.11/13a2.2.11 Primary system boundary interaction
: b. Level                                  events SHINE Medical Technologies                                        14a2-11                                                                Rev. 0
 
Chapter 14 - Technical Specifications                                                                                           Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 5 of 10)
Chapter/
Section/
Subsection Reference per ANSI/ANS-1 5.1-2007    Section Name                LCO or Condition                                        Basis 3.4          Containment
* Tritium purification system (TPS)     13a2.1.7/13a2.2.7 Mishandling or malfunction of equipment or                  glove box system or confinement      affecting the PSB Confinement
* IU and TOGS shielded cell            13a2.1.12.2/13a2.2.12.2 Irradiation facility fires confinement isolation valves
* RPF confinement isolation valves 3.5          Ventilation
* Ventilation systems (RCA ventilation 13a2.1.4/13a2.2.4 Mishandling or malfunction of target solution Systems            system Zone 1 [RVZ1]/RCA 13a2.1.7/13a2.2.7 Mishandling or malfunction of equipment ventilation system Zone 2 [RVZ2])
affecting the PSB
: a. Isolation dampers                    13a2.1.12.3/13a2.2.12.3 TPS design basis accident
: b. Filters                              13b.2.4 Critical equipment malfunction
* Process vessel vent system (PVVS): 13a2.1.5/13a2.2.5 Loss of off-site power Blowers operable 13a2.1.11/13a2.2.11 Primary system boundary interaction events 3.6          Emergency
* Emergency power system operable 13a2.1.5/13a2.2.5 Loss of off-site power Power                                                    13a2.1.11/13a2.2.11 Primary system boundary interaction events SHINE Medical Technologies                                        14a2-12                                                              Rev. 0
 
Chapter 14 - Technical Specifications                                                                                               Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 6 of 10)
Chapter/
Section/
Subsection Reference per ANSI/ANS-1 5.1-2007    Section Name                LCO or Condition                                        Basis 3.7          Radiation
* Noble gas storage tank activity     13b.2.4 Critical equipment malfunction Monitoring
* Target solution transfer decay time Systems and
* Radiation monitoring systems         13a2.1.4/13a2.2.4 Mishandling or malfunction of target solution Effluents        a. Channels and interlocks with        13a2.1.7/13a2.2.7 Mishandling or malfunction of equipment ventilation systems                affecting the PSB
: b. Monitoring equipment operable      13a2.1.12.3/13a2.2.12.3 TPS design basis accident 3.8          Experiments      N/A                                   N/A 3.9          Facility
* Criticality-safe sumps              13b.2.5 Inadvertent nuclear criticality in the radioisotope Specific LCOs    a. Sump pump operable                  production facility
: b. Sump level detectors operable
* Radiological Integrated Control Sys- 13b.2.4 Critical Equipment Malfunction tem (RICS)
SHINE Medical Technologies                                        14a2-13                                                                  Rev. 1
 
Chapter 14 - Technical Specifications                                                                                             Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 7 of 10)
Chapter/
Section/
Subsection Reference per ANSI/ANS-1 5.1-2007    Section Name                  Design Features                                            Basis 5              Design Features 5.1            Site and Facility
* Building design to resist external event 13a2.1.4/13a2.2.4 Mishandling or malfunction of target solution Description          such as airplane crash, tornados and 13a2.1.6/13a2.2.6 External events tornado missiles, high winds, floods, seismic events                          13a2.1.11/13a2.2.11 Primary system boundary interaction
* Robust design of IU and TOGS            events shielded cells                          13a2.1.12.1/13a2.2.12.2 Inadvertent exposure to neutrons from
* the neutron driver 13b.2.3 External events
* Pipe trench seals to mitigate the conse- 13b.2.4 Critical equipment malfunction quences of spills or leaks
* NGRS noble gas decay tank storage 13a2.1.11/13a2.2.11 Primary system boundary interaction cell designed to mitigate the            events consequences of leaks; NGRS 13b.2.4 Critical equipment malfunction backflow preventer design; NGRS and gas decay tanks integrity SHINE Medical Technologies                                        14a2-14                                                              Rev. 0
 
Chapter 14 - Technical Specifications                                                                                              Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 8 of 10)
Chapter/
Section/
Subsection Reference per ANSI/ANS-1 5.1-2007    Section Name                  Design Features                                            Basis 5.1 (contd)  Site and
* Facility berms, cell, and vault configu- 13b.3 Analysis of accidents with hazardous chemicals Facility            ration for chemical storage and pro-Description        cesses
* TPS cell volume combined with TPS        13a2.1.7/13a2.2.7 Mishandling or malfunction of equipment tritium inventory sufficient to maintain affecting the PSB less than LFL assuming a tritium leak
* Robust TPS confinement system            13a2.1.12.2/13a2.2.12.2 Irradiation facility fires design; tritium transport containers
* Fire resistant construction of          13b.2.6 Radioisotope production facility fire supercells, hot cells, tank enclosures, and process enclosures; three hour fire-rated barriers that separate fire areas
* Production facility biological shield;  13b.2.4 Critical equipment malfunction irradiation facility biological shield SHINE Medical Technologies                                          14a2-15                                                            Rev. 0
 
Chapter 14 - Technical Specifications                                                                                                Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 9 of 10)
Chapter/
Section/
Subsection Reference per ANSI/ANS-1 5.1-2007    Section Name                Design Features                                            Basis 5.1 (contd)  Site and
* RVZ1 ductwork robust design            13a2.1.4/13a2.2.4 Mishandling of target solution Facility 13a2.1.7/13a2.2.7 Mishandling or malfunction of equipment Description affecting the PSB 5.2          TSV Coolant
* Robust design of the TSV, TOGS,        13a2.1.2/13a2.2.2 Excess reactivity System              dump tank, piping and valves; and Design              light water pool; dump tank elevation 13a2.2.1 Target solution spill in the irradiation operations area relative to the TSV                    13a2.1.4/13a2.2.4 Mishandling or malfunction of target solution 13a2.1.5/13a2.2.5 Loss of off-site power 13a2.1.7 / 13a2.2.7 Mishandling or malfunction of equipment affecting the PSB 13a2.1.9 / 13a2.2.9 Detonation and deflagration in primary system boundary 5.3          Irradiation Unit
* Neutron driver access door interlock 13a2.1.12.1/13a2.2.12.2 Inadvertent exposure to neutrons from switch; thick walls in IU cell and    the neutron driver shield plug SHINE Medical Technologies                                          14a2-16                                                                Rev. 0
 
Chapter 14 - Technical Specifications                                                                                              Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 10 of 10)
Chapter/
Section/
Subsection Reference per ANSI/ANS-15.
1-2007    Section Name                  Design Feature                                        Basis 5.4            Fissionable
* Criticality safety design - TSV dump 13a2.1.2/13a2.2.2 Excess reactivity Material Storage    tank and RPF tanks; uranium storage; neutron absorber in tanks; 13b.2.5 Inadvertent nuclear criticality in the radioisotope criticality-safe containers, racks,    production facility sumps, vessels; concrete vault walls SHINE Medical Technologies                                          14a2-17                                                              Rev. 0
 
Chapter 14 - Technical Specifications                                          References 14a
 
==2.7    REFERENCES==
 
ANSI/ANS, 2007. The Development of Technical Specifications for Research Reactors, American National Standards Institute, ANSI/ANS-15.1, 2007.
SHINE Medical Technologies                14a2-18                                  Rev. 0
 
Chapter 14 - Technical Specifications                                                    Introduction 14b    TECHNICAL SPECIFICATIONS OF PROCESSES OUTSIDE THE IRRADIATION FACILITY This section encompasses the technical specifications for the processes involving special nuclear material (SNM), radioisotopes, and chemicals outside the IF produced from licensed materials.
In accordance with the requirements of 10 CFR 50.34 (a)(5), this section identifies the variables and conditions that will likely be the subjects of technical specifications for the SHINE facility.
These may change with the operating license application. These variables and conditions are based on the preliminary design of the SHINE facility. The technical specifications will be submitted with the operating license application.
These proposed technical specifications have been formulated on the premise that this material presents a sound framework upon which a final, complete set of specifications can be developed with the operating license application.
14b.1      INTRODUCTION The format and content of the Technical Specifications will be written with the guidance provided in ANSI/ANS 15.1 (ANSI/ANS 2007), NUREG-1537, and the Final ISG Augmenting NUREG-1537. The technical specifications for the facility outside the IF will comply with the regulations in 10 CFR 50.36 pertaining to a fuel reprocessing facility, as required by the Final ISG Augmenting NUREG-1537.
SHINE Medical Technologies                      14b-1                                          Rev. 1


tornado missiles, high winds, floods, seismic events*Robust design of IU and TOGS shielded cells
Chapter 14 - Technical Specifications          Safety Limits and Limiting Safety System Settings 14b.2      SAFETY LIMITS AND LIMITING SAFETY SYSTEM SETTINGS 14b.2.1      SAFETY LIMITS FOR PROCESSING IRRADIATED SPECIAL NUCLEAR MATERIAL OUTSIDE OF THE REACTOR For irradiated SNM outside of the TSV, SLs are derived for criticality accident prevention based on the Nuclear Criticality Safety Program, and also from an Integrated Safety Analysis (ISA).
*13a2.1.4/13a2.2.4 Mishandling or malfunction of target solution 13a2.1.6/13a2.2.6 External events 13a2.1.11/13a2.2.11 Primary system b oundary interaction events13a2.1.12.1/13a2.2.12.2 Inadvertent exposure to neutrons from the neutron driver13b.2.3 External events*Pipe trench seals to mitigate the conse-quences of spills or leaks13b.2.4 Critical equipment malfunction*NGRS noble gas decay tank storage cell designed to mitigate the consequences of leaks; NGRS backflow preventer design; NGRS and gas decay tanks integrity 13a2.1.11/13a2.2.11 Primary system b oundary interaction events13b.2.4 Critical equipment malfunction Chapter 14 - Technical Specifications IntroductionSHINE Medical Technologies14a2-15Rev. 0Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications(Sheet 8 of 10)Chapter/Section/ Subsection Reference per ANSI/ANS-15.1-2007Section NameDesign FeaturesBasis5.1 (cont'd)Site and FacilityDescription*Facility berms, cell, and vault configu-ration for chemical storage and pro-cesses13b.3 Analysis of accidents with hazardous chemicals*TPS cell volume combined with TPS tritium inventory sufficient to maintain less than LFL assuming a tritium leak*Robust TPS confinement system design; tritium transport containers 13a2.1.7/13a2.2.7 Mishandling or malfunction of equipment affecting the PSB 13a2.1.12.2/13a2.2.12.2 Irradiation facility fires *Fire resistant construction of supercells, hot cells, tank enclosures, and process enclosures; three hour fire-rated barriers that separate fire areas13b.2.6 Radioisotope production facility fire*Production facility biological shield; irradiation facility biological shield13b.2.4 Critical equipment malfunction Chapter 14 - Technical Specifications IntroductionSHINE Medical Technologies14a2-16Rev. 0Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications(Sheet 9 of 10)Chapter/Section/ Subsection Reference per ANSI/ANS-15.1-2007Section NameDesign FeaturesBasis5.1 (cont'd)Site and FacilityDescription*RVZ1 ductwork robust design13a2.1.4/13a2.2.4 Mishandling of target solution13a2.1.7/13a2.2.7 Mishandling or malfunction of equipment affecting the PSB5.2TSV Coolant System Design*Robust design of the TSV, TOGS, dump tank, piping and valves; and light water pool; dump tank elevation
Limits are specified, using the double-contingency principle, to avoid a criticality accident. Limits are set with a conservative margin.
For irradiated SNM outside of the TSV, appropriate limits are imposed pursuant to 10 CFR 50.36(c)(1) to ensure that fission products will be controlled to prevent excessive releases from the containment components, systems, or structures, particularly those structures, systems, and components containing large inventories of byproduct material.
14b.2.2      SAFETY LIMITS FOR PROCESSING UNIRRADIATED SPECIAL NUCLEAR MATERIAL OUTSIDE OF THE IRRADIATION FACILITY Limits are specified, using the double-contingency principle, to avoid a criticality accident. Limits are set with a conservative margin.
14b.2.3      SAFETY LIMITS FOR RADIOCHEMICAL PROCESSING Safety limits for radiochemical processing are developed to maintain operations within limits pursuant to 10 CFR 50.36 to protect the staff and the public. The amount of radiation is limited so as not to exceed the shielding and confinement capabilities of the systems and components in which the materials are processed or stored.
14b.2.4     SAFETY LIMITS FOR CHEMICAL PROCESSING Safety limits for chemical processing with hazardous chemicals that are conducted coincident to operations with SNM or radioactive material are developed in accordance with 10 CFR 50.36.
14b.2.5      LIMITING SAFETY SYSTEM SETTINGS For each process variable or parameter for which a SL is specified, and for which monitoring instruments are used, a protective operating limit is set to avoid exceeding the SL. This LSSS is calculated to provide a conservative margin below the SL and to account for overall measurement uncertainty, operating characteristics of control systems, and accuracy of control instrumentation. LSSSs will be established, as much as possible, to ensure adequate safety margins for each of the processes described above.
Refer to Table 14a2-1 for the SLs and LSSSs associated with the processes outside the irradiation facility.
SHINE Medical Technologies                    14b-2                                           Rev. 1


relative to the TSV13a2.1.2/13a2.2.2 Excess reactivity13a2.2.1 Target solution spill in the irradiation operations area13a2.1.4/13a2.2.4 Mishandling or malfunction of target solution 13a2.1.5/13a2.2.5 Loss of off-site power 13a2.1.7 / 13a2.2.7 Mishandling or malfunction of equipment affecting the PSB 13a2.1.9 / 13a2.2.9 Detonation and deflagration in primary system boundary5.3Irradiation Unit*Neutron driver access door interlock switch; thick walls in IU cell and
Chapter 14 - Technical Specifications                            Limiting Conditions for Operation 14b.3      LIMITING CONDITIONS FOR OPERATION LCOs are derived from the ISA and are administrative or engineered controls in addition to LSSSs that are put in place to ensure that operations are maintained within safe limits.
The LCOs will include the features discussed in the following subsections as appropriate. Refer to Table 14a2-1 for the LCOs associated with the processes outside the irradiation facility.
14b.3.1    PRIMARY PROCESS COMPONENTS AND SYSTEMS Processing SSCs and procedures that are designed and constructed to ensure that processing is conducted safely will have LCOs established for each of the processes defined in Section 14b.2 above.
14b.3.2   CONTAINMENT AND CONFINEMENT A confinement system is required as a result of the ISA and is defined as an LCO, pursuant to 10 CFR 50.36(c)(1).
14b.3.3    VENTILATION SYSTEMS The ISA prescribes the need for certain ventilation configurations, they are listed as an LCO pursuant to 10 CFR 50.36(c)(1).
14b.3.4    EMERGENCY ELECTRICAL POWER The ISA prescribes the need for emergency electrical power, the power supply is listed as an LCO pursuant to 10 CFR 50.36(c)(1).
14b.3.5    RADIATION MONITORING SYSTEMS AND EFFLUENTS Radiation monitoring systems and limits on effluents are specified as they pertain to the above-referenced processes, pursuant to 10 CFR 50.36(c)(1).
SHINE Medical Technologies                    14b-3                                        Rev. 0


shield plug13a2.1.12.1/13a2.2.12.2 Inadvertent exposure to neutrons from the neutron driver Chapter 14 - Technical Specifications IntroductionSHINE Medical Technologies14a2-17Rev. 0Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications(Sheet 10 of 10)
Chapter 14 - Technical Specifications                                 Surveillance Requirements 14b.4      SURVEILLANCE REQUIREMENTS Surveillance requirements will be provided in the technical specifications.
Chapter/Section/ Subsection Reference per ANSI/ANS-15.1-2007Section NameDesign FeatureBasis5.4Fissionable Material Storage*Criticality safety design - TSV dump tank and RPF tanks; uranium storage; neutron absorber in tanks; criticality-safe containers, racks, sumps, vessels; concrete vault walls13a2.1.2/13a2.2.2 Excess reactivity13b.2.5 Inadvertent nuclear criticality in the radioisotope production facility Chapter 14 - Technical SpecificationsReferencesSHINE Medical Technologies14a2-18Rev. 014a
SHINE Medical Technologies                    14b-4                                        Rev. 0


==2.7REFERENCES==
Chapter 14 - Technical Specifications                                              Design Features 14b.5        DESIGN FEATURES Design features that will be provided in the technical specifications are the features of the SHINE facility, such as materials of construction and geometric arrangements that would have a significant effect on safety if these features were altered or modified. The requirements of 10 CFR 50.36(c)(4) are specified here as they pertain to the above referenced processes. Refer to Table 14a2-1 for the design features associated with the processes outside the irradiation facility SHINE Medical Technologies                      14b-5                                          Rev. 0


ANSI/ANS, 2007.
Chapter 14 - Technical Specifications                                     Administrative Controls 14b.6    ADMINISTRATIVE CONTROLS See Section 14a2.6 for examples of Administrative Controls that will be in use at the SHINE Facility.
The Development of Technical Specifications for Research Reactors, American National Standards Institute, ANSI/ANS-15.1, 2007.
The remaining administrative controls will be provided in the technical specifications.
Chapter 14 - Technical SpecificationsIntroductionSHINE Medical Technologies14b-1Rev. 114bTECHNICAL SPECIFICATIONS OF PROCESSES OUTSIDE THE IRRADIATION FACILITYThis section encompasses the technical spec ifications for the processes involving special nuclear material (SNM), radioisotopes, and chemicals outside the IF produced from licensed
SHINE Medical Technologies                    14b-6                                      Rev. 1


materials.In accordance with the requirements of 10 CFR 50.34 (a)(5), this section identifies the variables and conditions that will likely be the subjects of technical specifications for the SHINE facility.
Chapter 14 - Technical Specifications                                          References 14b.7    REFERENCES ANSI/ANS, 2007. The Development of Technical Specifications for Research Reactors, American National Standards Institute, ANSI/ANS-15.1, 2007 SHINE Medical Technologies                  14b-7                                  Rev. 0}}
These may change with the operating license ap plication. These variables and conditions are based on the preliminary design of the SHINE facility. The technical specifications will be submitted with the operating license application.These proposed technical specifications have been formulated on the premise that this material presents a sound framework upon which a final, complete set of specifications can be developed with the operating license application. 14b.1INTRODUCTIONThe format and content of the Technical Sp ecifications will be written with the guidance providedin ANSI/ANS 15.1 (ANSI/ANS 2007), NUREG-1537, and the Final ISG Augmenting NUREG-1537. The technical specifications for the facility outside the IF will comply with the regulations in 10 CFR 50.36 pertaining to a fuel reprocessing facility, as required by the Final ISG Augmenting NUREG-1537.
Chapter 14 - Technical SpecificationsSafety Limits and Limiting Safety System SettingsSHINE Medical Technologies14b-2Rev. 114b.2SAFETY LIMITS AND LIMITING SAFETY SYSTEM SETTINGS14b.2.1SAFETY LIMITS FOR PROCESSING IRRADIATED SPECIAL NUCLEAR MATERIAL OUTSIDE OF THE REACTORFor irradiated SNM outside of the TSV, SLs are derived for criticality accident prevention based on the Nuclear Criticality Safety Program, and also from an Integrated Safety Analysis (ISA).
Limits are specified, using the double-contingency principle, to avoid a criticality accident. Limits are set with a conservative margin.For irradiated SNM outside of the TSV, appropriate limits are imposed pursuant to 10CFR50.36(c)(1) to ensure that fission products will be controlled to prevent excessive releases from the containment components, systems, or structures, particularly those structures, systems, and components containing large inventories of byproduct material.14b.2.2SAFETY LIMITS FOR PROCESSING UNIRRADIATED SPECIAL NUCLEAR MATERIAL OUTSIDE OF THE IRRADIATION FACILITY Limits are specified, using the d ouble-contingency principle, to avoid a criticality accident. Limits are set with a conservative margin.14b.2.3SAFETY LIMITS FOR RADIOCHEMICAL PROCESSING Safety limits for radiochemical processing are developed to maintain operations within limits pursuant to 10 CFR 50.36 to protect the staff and the public. The amount of radiation is limited so as not to exceed the shielding and confinement capabilities of the systems and components in which the materials are processed or stored.14b.2.4SAFETY LIMITS FOR CHEMICAL PROCESSINGSafety limits for chemical processing with hazardous chemicals that are conducted coincident to operations with SNM or radioactive material are developed in accordance with 10 CFR 50.36. 14b.2.5LIMITING SAFETY SYSTEM SETTINGS For each process variable or parameter for whic h a SL is specified, and for which monitoring instruments are used, a protective operating limit is set to avoid exceeding the SL. This LSSS is calculated to provide a conservative margin below the SL and to account for overall measurement uncertainty, operating characteristics of control systems, and accuracy of control instrumentation. LSSSs will be established, as much as possible, to ensure adequate safety margins for each of the processes described above.Refer to Table 14a2-1 for the SLs and LSSSs associated with the processes outside the irradiation facility.
Chapter 14 - Technical SpecificationsLimiting Conditions for OperationSHINE Medical Technologies14b-3Rev. 014b.3LIMITING CONDITIONS FOR OPERATIONLCOs are derived from the ISA and are administrative or engineered controls in addition to LSSSs that are put in place to ensure that operations are maintained within safe limits.The LCOs will include the features discussed in the following subsections as appropriate. Refer to Table 14a2-1 for the LCOs associated with the processes outside the irradiation facility.14b.3.1PRIMARY PROCESS COMPONENTS AND SYSTEMSProcessing SSCs and procedures that are designed and constructed to ensure that processing is conducted safely will have LCOs established for eac h of the processes defined in Section 14b.2 above.14b.3.2CONTAINMENT AND CONFINEMENT A confinement system is required as a result of the ISA and is defined as an LCO, pursuant to 10CFR 50.36(c)(1).14b.3.3VENTILATION SYSTEMS The ISA prescribes the need for certain ventilat ion configurations, they are listed as an LCO pursuant to 10 CFR 50.36(c)(1).14b.3.4EMERGENCY ELECTRICAL POWERThe ISA prescribes the need for emergency electrical power, the power supply is listed as an LCO pursuant to 10 CFR 50.36(c)(1).14b.3.5RADIATION MONITORING SYSTEMS AND EFFLUENTSRadiation monitoring systems and limits on effluents are specified as they pertain to the above-referenced processes, pursuant to 10 CFR 50.36(c)(1).
Chapter 14 - Technical SpecificationsSurveillance RequirementsSHINE Medical Technologies14b-4Rev. 014b.4SURVEILLANCE REQUIREMENTSSurveillance requirements will be provided in the technical specifications.
Chapter 14 - Technical SpecificationsDesign FeaturesSHINE Medical Technologies14b-5Rev. 014b.5DESIGN FEATURESDesign features that will be provided in the technical specifications are the features of the SHINE facility, such as materials of construction and geometric arrangements that would have a significant effect on safety if these features were altered or modified. The requirements of 10CFR 50.36(c)(4) are specified here as they pertain to the above referenced processes
.Referto Table 14a2-1 for the design features associated with the processes outside the irradiation facility Chapter 14 - Technical SpecificationsAdministrative ControlsSHINE Medical Technologies14b-6Rev. 114b.6ADMINISTRATIVE CONTROLSSee Section 14a2.6 for examples of Administrative Controls that will be in use at the SHINE Facility.The remaining administrative controls will be provided in the technical specifications.
Chapter 14 - Technical SpecificationsReferencesSHINE Medical Technologies14b-7Rev. 014b.7REFERENCES ANSI/ANS, 2007.
The Development of Technical Specifications for Research Reactors, American National Standards Institute, ANSI/ANS-15.1, 2007}}

Latest revision as of 11:54, 31 October 2019

Shine Medical Technologies V. 0 - Chapter 14 - Technical Specifications
ML15147A222
Person / Time
Site: SHINE Medical Technologies
Issue date: 05/14/2015
From: Bynum R
Shine Medical Technologies
To:
Office of Nuclear Reactor Regulation
Lynch S
References
SHINE, SHINE.SUBMISSION.16, SHN.PSAR.P, SHN.PSAR.P.7
Download: ML15147A222 (30)


Text

Chapter 14 - Technical Specifications Table of Contents CHAPTER 14 TECHNICAL SPECIFICATIONS Table of Contents Section Title Page 14a1 HETEROGENEOUS REACTOR TECHNICAL SPECIFICATIONS .............14a1-1 14a2 IRRADIATION FACILITY TECHNICAL SPECIFICATIONS.........................14a2-1 14a

2.1 INTRODUCTION

.........................................................................................14a2-2 14a2.2 SAFETY LIMITS AND LIMITING SAFETY SYSTEM SETTINGS................14a2-3 14a2.3 LIMITING CONDITIONS FOR OPERATION ...............................................14a2-4 14a2.4 SURVEILLANCE REQUIREMENTS............................................................14a2-5 14a2.5 DESIGN FEATURES ...................................................................................14a2-6 14a2.6 ADMINISTRATIVE CONTROLS ..................................................................14a2-7 14a

2.7 REFERENCES

............................................................................................14a2-18 14b TECHNICAL SPECIFICATIONS OF PROCESSES OUTSIDE THE IRRADIATION FACILITY .............................................................................14b-1 14b.1 INTRODUCTION .........................................................................................14b-1 14b.2 SAFETY LIMITS AND LIMITING SAFETY SYSTEM SETTINGS................14b-2 14b.2.1 SAFETY LIMITS FOR PROCESSING IRRADIATED SPECIAL NUCLEAR MATERIAL OUTSIDE OF THE REACTOR ...............................14b-2 14b.2.2 SAFETY LIMITS FOR PROCESSING UNIRRADIATED SPECIAL NUCLEAR MATERIAL OUTSIDE OF THE IRRADIATION FACILITY ........14b-2 14b.2.3 SAFETY LIMITS FOR RADIOCHEMICAL PROCESSING ..........................14b-2 14b.2.4 SAFETY LIMITS FOR CHEMICAL PROCESSING .....................................14b-2 14b.2.5 LIMITING SAFETY SYSTEM SETTINGS....................................................14b-2 14b.3 LIMITING CONDITIONS FOR OPERATION ...............................................14b-3 14b.3.1 PRIMARY PROCESS COMPONENTS AND SYSTEMS.............................14b-3 14b.3.2 CONTAINMENT AND CONFINEMENT.......................................................14b-3 14b.3.3 VENTILATION SYSTEMS ...........................................................................14b-3 14b.3.4 EMERGENCY ELECTRICAL POWER ........................................................14b-3 14b.3.5 RADIATION MONITORING SYSTEMS AND EFFLUENTS ........................14b-3 14b.4 SURVEILLANCE REQUIREMENTS............................................................14b-4 14b.5 DESIGN FEATURES ...................................................................................14b-5 14b.6 ADMINISTRATIVE CONTROLS ..................................................................14b-6 14b.7 REFERENCES ............................................................................................14b-7 SHINE Medical Technologies 14-i Rev. 0

Chapter 14 - Technical Specifications List of Tables List of Tables Number Title 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications SHINE Medical Technologies 14-ii Rev. 0

Chapter 14 - Technical Specifications List of Figures List of Figures Number Title None SHINE Medical Technologies 14-iii Rev. 0

Chapter 14 - Technical Specifications Acronyms and Abbreviations Acronyms and Abbreviations Acronym/Abbreviation Definition 10 CFR Title 10 of the Code of Federal Regulations ANS American Nuclear Society ANSI American National Standards Institute IF irradiation facility ISA Integrated Safety Analysis IU irradiation unit LCO limiting condition of operation LSSS limiting safety system setting LWPS light water pool system NGRS noble gas removal system PCLS primary closed loop cooling system PSB primary system boundary PVVS process vessel vent system RCA radiologically controlled area RPF radioisotope production facility RVZ1 RCA ventilation system Zone 1 RVZ2 RCA ventilation system Zone 2 SHINE SHINE Medical Technologies, Inc.

SL safety limit SNM special nuclear material TOGS TSV off-gas system TSV target solution vessel SHINE Medical Technologies 14-iv Rev. 1

Chapter 14 - Technical Specifications Heterogeneous Reactor Technical Specifications CHAPTER 14 TECHNICAL SPECIFICATION 14a1 HETEROGENEOUS REACTOR TECHNICAL SPECIFICATIONS The SHINE Medical Technologies, Inc. (SHINE) facility is not a heterogeneous reactor facility; therefore, this section does not apply.

SHINE Medical Technologies 14a1-1 Rev. 0

Chapter 14 - Technical Specifications Irradiation Facility Technical Specifications 14a2 IRRADIATION FACILITY TECHNICAL SPECIFICATIONS This section encompasses the technical specifications for the processes involving special nuclear material (SNM), radioisotopes, and chemicals inside the irradiation facility (IF).

In accordance with the requirements of Title 10 of the Code of Federal Regulations (10 CFR) 50.34 (a)(5), this section identifies the variables and conditions that will likely be the subjects of technical specifications for the SHINE facility. These may change with the operating license application. These variables and conditions are based on the preliminary design of the SHINE facility. The technical specifications will be submitted with the operating license application.

These proposed variables have been identified on the premise that this material presents a sound framework upon which a final, complete set of technical specifications can be provided with the operating license application.

SHINE Medical Technologies 14a2-1 Rev. 0

Chapter 14 - Technical Specifications Introduction 14a

2.1 INTRODUCTION

The format and content of the technical specifications will be written with the guidance provided in American National Standards Institute (ANSI)/American Nuclear Society (ANS) 15.1, The Development of Technical Specifications for Research Reactors (ANSI/ANS, 2007). The technical specifications for non-power reactors include the categories in 10 CFR 50.36 for production and utilization facilities.

Normal operation of the SHINE facility within the limits of technical specifications will not result in off-site radiation exposure in excess of 10 CFR 20 guidelines.

SHINE Medical Technologies 14a2-2 Rev. 0

Chapter 14 - Technical Specifications Safety Limits and Limiting Safety System Settings 14a2.2 SAFETY LIMITS AND LIMITING SAFETY SYSTEM SETTINGS Safety limits (SLs) will be placed on important process variables as necessary to reasonably preserve the integrity of the primary system boundary (PSB) and prevent the uncontrolled release of radioactivity. For the SHINE IF, the PSB is the target solution vessel (TSV), TSV dump tank, TSV off-gas system (TOGS), and associated piping and components. SLs may also be established for the character and quality of the target solution.

Limiting safety system settings (LSSSs) are settings for automatic protective devices related to those variables having significant safety functions. These settings ensure that automatic protective action will correct the abnormal situation before an SL is exceeded.

Refer to Table 14a2-1 for the SLs and LSSSs associated with the PSB. The justifications for the variables chosen are given in the section/subsection listed in the Table 14a2-1.

SHINE Medical Technologies 14a2-3 Rev. 0

Chapter 14 - Technical Specifications Limiting Conditions for Operation 14a2.3 LIMITING CONDITIONS FOR OPERATION Limiting conditions of operations (LCOs) are derived from the safety analyses and are implemented administratively or by control and monitoring circuitry to ensure safe operation of the irradiation facility. The LCOs are the lowest functional capability or performance level required for safe operation of the irradiation facility.

Table 14a2-1 shows LCOs associated with the irradiation facility. The justifications for the variables chosen are given in the sections listed in the table.

SHINE Medical Technologies 14a2-4 Rev. 0

Chapter 14 - Technical Specifications Surveillance Requirements 14a2.4 SURVEILLANCE REQUIREMENTS Surveillance requirements will be provided in the technical specifications.

SHINE Medical Technologies 14a2-5 Rev. 0

Chapter 14 - Technical Specifications Design Features 14a2.5 DESIGN FEATURES Design features that will be provided in the technical specifications are the features of the SHINE facility, such as materials of construction and geometric arrangements that would have a significant effect on safety if these features were altered or modified. The requirements of 10 CFR 50.36(c)(4) are specified here as they pertain to the above referenced processes (see Table 14a2-1).

SHINE Medical Technologies 14a2-6 Rev. 0

Chapter 14 - Technical Specifications Administrative Controls 14a2.6 ADMINISTRATIVE CONTROLS Administrative controls will be provided in the technical specifications.

Examples of the proposed subjects of administrative controls are provided below:

Procedures Written procedures shall be established, implemented, and maintained covering activities described in the following Programs.

Programs

  • Criticality-safety
  • ALARA (includes use of accelerator and hot cell audible and visual warnings)
  • Procurement and use of transport and waste containers
  • Fire protection (includes installed and transient combustible loading, performance of hot work, deuterium source vessel integrity, fire watch requirements, use and storage of flammable and combustible liquids and gasses)
  • Solvent control (includes control of process residence times, solvent quality control, and solvent solution sampling and analysis)
  • Tritium control (includes inventory control and sampling)
  • Light water coolant activity monitoring
  • Chemical control SHINE Medical Technologies 14a2-7 Rev. 1

Chapter 14 - Technical Specifications Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 1 of 10)

Chapter/

Section/

Subsection Reference per ANSI/ANS-1 5.1-2007 Section Name SLs and LSSS Basis 2 SLs and LSSS 2.1 SLs

  • TSV power 13a2.1.8/13a2.2.8 Large undamped power oscillations
  • Uranium concentration 13a2.1.2/13a2.2.2 Insertion of excess reactivity
  • Uranium enrichment 13a2.1.11/13a2.2.11 PSB System interaction events
  • Quantities of radioactive materials 13b.2.4 Critical equipment malfunction 13b.2.5 Inadvertent nuclear criticality in the radioisotope production facility 13b.2.6 Radioisotope production facility fire 2.2 Limiting Safety
  • TSV LSSS 13a2.1.2/13a2.2.2 Excess reactivity System a. TSV cover gas hydrogen 13a2.1.8/13a2.2.8 Large undamped power oscillations Settings concentration high 13a2.1.9/13a2.2.9 Detonation and deflagration in primary system boundary
b. TSV neutron flux high, source range
c. TSV neutron flux high, high range SHINE Medical Technologies 14a2-8 Rev. 1

Chapter 14 - Technical Specifications Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 2 of 10)

Chapter/

Section/

Subsection Reference per ANSI/ANS-1 5.1-2007 Section Name LCO or Condition Basis 3 LCOs 3.1 TSV and

  • Target solution parameters: 13a2.1.2/13a2.2.2 Excess reactivity Target a. Precipitation catalyst 13a2.1.8/13a2.2.8 Large undamped power oscillations Solution concentration 13a2.1.11/13a2.2.11 Primary system boundary interaction Parameters events
b. Uranium concentration
c. Uranium enrichment
d. Fission product activity based on the maximum number of cycles prior to target solution cleanup
  • TSV parameters and 13a2.1.2/13a2.2.2 Excess reactivity operational constraints: 13a2.1.3/13a2.2.3 Reduction of cooling
a. High fill flow rate 13a2.1.8/13a2.2.8 Large undamped power oscillations
b. Maximum bulk temperature
c. Minimum bulk temperature
d. Void coefficient design value
e. Temperature coefficient design value SHINE Medical Technologies 14a2-9 Rev. 0

Chapter 14 - Technical Specifications Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 3 of 10)

Chapter/

Section/

Subsection Reference per ANSI/ANS-1 5.1-2007 Section Name LCO or Condition Basis 3.2 TSV Control

  • TRPS: Required channels 13a2.1.2/13a2.2.2 Excess reactivity and Safety operable per Table 3.2.1 13a2.1.3/13a2.2.3 Reduction of cooling Systems Table 3.2.1 (Channel monitored, 13a2.1.8/13a2.2.8 Large undamped power oscillations number of channels required, allowable value, nominal setpoint, 13a2.1.9/13a2.2.9 Detonation and deflagration in primary permissible bypass or other system boundary conditions)
a. TSV cover gas hydrogen concentration high
b. TSV neutron flux high, source range
c. TSV neutron flux high, high range
d. Loss of PCLS flow
e. High PCLS temperature
f. Primary closed loop cooling system (PCLS) low temperature
g. ESFAS
h. Manual SHINE Medical Technologies 14a2-10 Rev. 0

Chapter 14 - Technical Specifications Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 4 of 10)

Chapter/

Section/

Subsection Reference per ANSI/ANS-1 5.1-2007 Section Name LCO or Condition Basis 3.2 TSV Control and

  • TOGS 13a2.1.5/13a2.2.5 Loss of off-site power (contd) Safety Systems a. TOGS operable and in operation 13a2.1.11/13a2.2.11 Primary system boundary interaction (operable includes blowers, events recombiner beds, and interlock with 13b.2.1 Maximum hypothetical accident in the radioisotope noble gas removal system [NGRS])

production facility (RPF)

b. Hydrogen monitoring indication
c. Hydrogen concentration within limits
  • Safety system equipment 13a2.1.2/13a2.2.2 Excess reactivity
a. TSV dump valves 13a2.1.3/13a2.2.3 Reduction of cooling
b. Neutron driver circuit breakers 13a2.1.8/13a2.2.8 Large undamped power oscillations
c. Neutron driver interlock with TSV fill 13a2.1.9/13a2.2.9 Detonation and deflagration in primary system operation boundary
d. Dump tank empty during startup and irradiation
e. Fill valves 3.3 Coolant
  • Light water pool system (LWPS) 13a2.1.2/13a2.2.2 Excess reactivity Systems a. Temperature upper limit and 13a2.1.3/13a2.2.3 Reduction of cooling temperature lower limit 13a2.1.11/13a2.2.11 Primary system boundary interaction
b. Level events SHINE Medical Technologies 14a2-11 Rev. 0

Chapter 14 - Technical Specifications Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 5 of 10)

Chapter/

Section/

Subsection Reference per ANSI/ANS-1 5.1-2007 Section Name LCO or Condition Basis 3.4 Containment

  • Tritium purification system (TPS) 13a2.1.7/13a2.2.7 Mishandling or malfunction of equipment or glove box system or confinement affecting the PSB Confinement
  • IU and TOGS shielded cell 13a2.1.12.2/13a2.2.12.2 Irradiation facility fires confinement isolation valves
  • RPF confinement isolation valves 3.5 Ventilation
  • Ventilation systems (RCA ventilation 13a2.1.4/13a2.2.4 Mishandling or malfunction of target solution Systems system Zone 1 [RVZ1]/RCA 13a2.1.7/13a2.2.7 Mishandling or malfunction of equipment ventilation system Zone 2 [RVZ2])

affecting the PSB

a. Isolation dampers 13a2.1.12.3/13a2.2.12.3 TPS design basis accident
b. Filters 13b.2.4 Critical equipment malfunction
  • Process vessel vent system (PVVS): 13a2.1.5/13a2.2.5 Loss of off-site power Blowers operable 13a2.1.11/13a2.2.11 Primary system boundary interaction events 3.6 Emergency
  • Emergency power system operable 13a2.1.5/13a2.2.5 Loss of off-site power Power 13a2.1.11/13a2.2.11 Primary system boundary interaction events SHINE Medical Technologies 14a2-12 Rev. 0

Chapter 14 - Technical Specifications Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 6 of 10)

Chapter/

Section/

Subsection Reference per ANSI/ANS-1 5.1-2007 Section Name LCO or Condition Basis 3.7 Radiation

  • Noble gas storage tank activity 13b.2.4 Critical equipment malfunction Monitoring
  • Target solution transfer decay time Systems and
  • Radiation monitoring systems 13a2.1.4/13a2.2.4 Mishandling or malfunction of target solution Effluents a. Channels and interlocks with 13a2.1.7/13a2.2.7 Mishandling or malfunction of equipment ventilation systems affecting the PSB
b. Monitoring equipment operable 13a2.1.12.3/13a2.2.12.3 TPS design basis accident 3.8 Experiments N/A N/A 3.9 Facility
  • Criticality-safe sumps 13b.2.5 Inadvertent nuclear criticality in the radioisotope Specific LCOs a. Sump pump operable production facility
b. Sump level detectors operable
  • Radiological Integrated Control Sys- 13b.2.4 Critical Equipment Malfunction tem (RICS)

SHINE Medical Technologies 14a2-13 Rev. 1

Chapter 14 - Technical Specifications Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 7 of 10)

Chapter/

Section/

Subsection Reference per ANSI/ANS-1 5.1-2007 Section Name Design Features Basis 5 Design Features 5.1 Site and Facility

  • Building design to resist external event 13a2.1.4/13a2.2.4 Mishandling or malfunction of target solution Description such as airplane crash, tornados and 13a2.1.6/13a2.2.6 External events tornado missiles, high winds, floods, seismic events 13a2.1.11/13a2.2.11 Primary system boundary interaction
  • Robust design of IU and TOGS events shielded cells 13a2.1.12.1/13a2.2.12.2 Inadvertent exposure to neutrons from
  • the neutron driver 13b.2.3 External events
  • Pipe trench seals to mitigate the conse- 13b.2.4 Critical equipment malfunction quences of spills or leaks
  • NGRS noble gas decay tank storage 13a2.1.11/13a2.2.11 Primary system boundary interaction cell designed to mitigate the events consequences of leaks; NGRS 13b.2.4 Critical equipment malfunction backflow preventer design; NGRS and gas decay tanks integrity SHINE Medical Technologies 14a2-14 Rev. 0

Chapter 14 - Technical Specifications Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 8 of 10)

Chapter/

Section/

Subsection Reference per ANSI/ANS-1 5.1-2007 Section Name Design Features Basis 5.1 (contd) Site and

  • Facility berms, cell, and vault configu- 13b.3 Analysis of accidents with hazardous chemicals Facility ration for chemical storage and pro-Description cesses
  • TPS cell volume combined with TPS 13a2.1.7/13a2.2.7 Mishandling or malfunction of equipment tritium inventory sufficient to maintain affecting the PSB less than LFL assuming a tritium leak
  • Robust TPS confinement system 13a2.1.12.2/13a2.2.12.2 Irradiation facility fires design; tritium transport containers
  • Fire resistant construction of 13b.2.6 Radioisotope production facility fire supercells, hot cells, tank enclosures, and process enclosures; three hour fire-rated barriers that separate fire areas
  • Production facility biological shield; 13b.2.4 Critical equipment malfunction irradiation facility biological shield SHINE Medical Technologies 14a2-15 Rev. 0

Chapter 14 - Technical Specifications Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 9 of 10)

Chapter/

Section/

Subsection Reference per ANSI/ANS-1 5.1-2007 Section Name Design Features Basis 5.1 (contd) Site and

  • RVZ1 ductwork robust design 13a2.1.4/13a2.2.4 Mishandling of target solution Facility 13a2.1.7/13a2.2.7 Mishandling or malfunction of equipment Description affecting the PSB 5.2 TSV Coolant
  • Robust design of the TSV, TOGS, 13a2.1.2/13a2.2.2 Excess reactivity System dump tank, piping and valves; and Design light water pool; dump tank elevation 13a2.2.1 Target solution spill in the irradiation operations area relative to the TSV 13a2.1.4/13a2.2.4 Mishandling or malfunction of target solution 13a2.1.5/13a2.2.5 Loss of off-site power 13a2.1.7 / 13a2.2.7 Mishandling or malfunction of equipment affecting the PSB 13a2.1.9 / 13a2.2.9 Detonation and deflagration in primary system boundary 5.3 Irradiation Unit
  • Neutron driver access door interlock 13a2.1.12.1/13a2.2.12.2 Inadvertent exposure to neutrons from switch; thick walls in IU cell and the neutron driver shield plug SHINE Medical Technologies 14a2-16 Rev. 0

Chapter 14 - Technical Specifications Introduction Table 14a2-1 SHINE Facility Proposed Parameters for Technical Specifications (Sheet 10 of 10)

Chapter/

Section/

Subsection Reference per ANSI/ANS-15.

1-2007 Section Name Design Feature Basis 5.4 Fissionable

  • Criticality safety design - TSV dump 13a2.1.2/13a2.2.2 Excess reactivity Material Storage tank and RPF tanks; uranium storage; neutron absorber in tanks; 13b.2.5 Inadvertent nuclear criticality in the radioisotope criticality-safe containers, racks, production facility sumps, vessels; concrete vault walls SHINE Medical Technologies 14a2-17 Rev. 0

Chapter 14 - Technical Specifications References 14a

2.7 REFERENCES

ANSI/ANS, 2007. The Development of Technical Specifications for Research Reactors, American National Standards Institute, ANSI/ANS-15.1, 2007.

SHINE Medical Technologies 14a2-18 Rev. 0

Chapter 14 - Technical Specifications Introduction 14b TECHNICAL SPECIFICATIONS OF PROCESSES OUTSIDE THE IRRADIATION FACILITY This section encompasses the technical specifications for the processes involving special nuclear material (SNM), radioisotopes, and chemicals outside the IF produced from licensed materials.

In accordance with the requirements of 10 CFR 50.34 (a)(5), this section identifies the variables and conditions that will likely be the subjects of technical specifications for the SHINE facility.

These may change with the operating license application. These variables and conditions are based on the preliminary design of the SHINE facility. The technical specifications will be submitted with the operating license application.

These proposed technical specifications have been formulated on the premise that this material presents a sound framework upon which a final, complete set of specifications can be developed with the operating license application.

14b.1 INTRODUCTION The format and content of the Technical Specifications will be written with the guidance provided in ANSI/ANS 15.1 (ANSI/ANS 2007), NUREG-1537, and the Final ISG Augmenting NUREG-1537. The technical specifications for the facility outside the IF will comply with the regulations in 10 CFR 50.36 pertaining to a fuel reprocessing facility, as required by the Final ISG Augmenting NUREG-1537.

SHINE Medical Technologies 14b-1 Rev. 1

Chapter 14 - Technical Specifications Safety Limits and Limiting Safety System Settings 14b.2 SAFETY LIMITS AND LIMITING SAFETY SYSTEM SETTINGS 14b.2.1 SAFETY LIMITS FOR PROCESSING IRRADIATED SPECIAL NUCLEAR MATERIAL OUTSIDE OF THE REACTOR For irradiated SNM outside of the TSV, SLs are derived for criticality accident prevention based on the Nuclear Criticality Safety Program, and also from an Integrated Safety Analysis (ISA).

Limits are specified, using the double-contingency principle, to avoid a criticality accident. Limits are set with a conservative margin.

For irradiated SNM outside of the TSV, appropriate limits are imposed pursuant to 10 CFR 50.36(c)(1) to ensure that fission products will be controlled to prevent excessive releases from the containment components, systems, or structures, particularly those structures, systems, and components containing large inventories of byproduct material.

14b.2.2 SAFETY LIMITS FOR PROCESSING UNIRRADIATED SPECIAL NUCLEAR MATERIAL OUTSIDE OF THE IRRADIATION FACILITY Limits are specified, using the double-contingency principle, to avoid a criticality accident. Limits are set with a conservative margin.

14b.2.3 SAFETY LIMITS FOR RADIOCHEMICAL PROCESSING Safety limits for radiochemical processing are developed to maintain operations within limits pursuant to 10 CFR 50.36 to protect the staff and the public. The amount of radiation is limited so as not to exceed the shielding and confinement capabilities of the systems and components in which the materials are processed or stored.

14b.2.4 SAFETY LIMITS FOR CHEMICAL PROCESSING Safety limits for chemical processing with hazardous chemicals that are conducted coincident to operations with SNM or radioactive material are developed in accordance with 10 CFR 50.36.

14b.2.5 LIMITING SAFETY SYSTEM SETTINGS For each process variable or parameter for which a SL is specified, and for which monitoring instruments are used, a protective operating limit is set to avoid exceeding the SL. This LSSS is calculated to provide a conservative margin below the SL and to account for overall measurement uncertainty, operating characteristics of control systems, and accuracy of control instrumentation. LSSSs will be established, as much as possible, to ensure adequate safety margins for each of the processes described above.

Refer to Table 14a2-1 for the SLs and LSSSs associated with the processes outside the irradiation facility.

SHINE Medical Technologies 14b-2 Rev. 1

Chapter 14 - Technical Specifications Limiting Conditions for Operation 14b.3 LIMITING CONDITIONS FOR OPERATION LCOs are derived from the ISA and are administrative or engineered controls in addition to LSSSs that are put in place to ensure that operations are maintained within safe limits.

The LCOs will include the features discussed in the following subsections as appropriate. Refer to Table 14a2-1 for the LCOs associated with the processes outside the irradiation facility.

14b.3.1 PRIMARY PROCESS COMPONENTS AND SYSTEMS Processing SSCs and procedures that are designed and constructed to ensure that processing is conducted safely will have LCOs established for each of the processes defined in Section 14b.2 above.

14b.3.2 CONTAINMENT AND CONFINEMENT A confinement system is required as a result of the ISA and is defined as an LCO, pursuant to 10 CFR 50.36(c)(1).

14b.3.3 VENTILATION SYSTEMS The ISA prescribes the need for certain ventilation configurations, they are listed as an LCO pursuant to 10 CFR 50.36(c)(1).

14b.3.4 EMERGENCY ELECTRICAL POWER The ISA prescribes the need for emergency electrical power, the power supply is listed as an LCO pursuant to 10 CFR 50.36(c)(1).

14b.3.5 RADIATION MONITORING SYSTEMS AND EFFLUENTS Radiation monitoring systems and limits on effluents are specified as they pertain to the above-referenced processes, pursuant to 10 CFR 50.36(c)(1).

SHINE Medical Technologies 14b-3 Rev. 0

Chapter 14 - Technical Specifications Surveillance Requirements 14b.4 SURVEILLANCE REQUIREMENTS Surveillance requirements will be provided in the technical specifications.

SHINE Medical Technologies 14b-4 Rev. 0

Chapter 14 - Technical Specifications Design Features 14b.5 DESIGN FEATURES Design features that will be provided in the technical specifications are the features of the SHINE facility, such as materials of construction and geometric arrangements that would have a significant effect on safety if these features were altered or modified. The requirements of 10 CFR 50.36(c)(4) are specified here as they pertain to the above referenced processes. Refer to Table 14a2-1 for the design features associated with the processes outside the irradiation facility SHINE Medical Technologies 14b-5 Rev. 0

Chapter 14 - Technical Specifications Administrative Controls 14b.6 ADMINISTRATIVE CONTROLS See Section 14a2.6 for examples of Administrative Controls that will be in use at the SHINE Facility.

The remaining administrative controls will be provided in the technical specifications.

SHINE Medical Technologies 14b-6 Rev. 1

Chapter 14 - Technical Specifications References 14b.7 REFERENCES ANSI/ANS, 2007. The Development of Technical Specifications for Research Reactors, American National Standards Institute, ANSI/ANS-15.1, 2007 SHINE Medical Technologies 14b-7 Rev. 0